Re­call re­port: Pfiz­er pulls even more Chan­tix lots as ni­trosamine con­t­a­m­i­na­tion wor­ries grow

It’s been a month since Pfiz­er was forced to re­call bot­tles of its an­ti-smok­ing drug Chan­tix, but the counter was set back to ze­ro last …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.